SwissMedic-2021-0089-V389

Type IB variation for application SwissMedic-2021-0089. Type IB variation: Container Closure Change for Atezolimumab-R — minor update

Variation Number
SwissMedic-2021-0089-V389
Type
Type IB
Application
SwissMedic-2021-0089
Change
CHG-2024-0089
Status
Active
Fee
€3,507
Submitted
2024-04-12
Approved
—
Description

Type IB variation: Container Closure Change for Atezolimumab-R — minor update